Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 13, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness